Genetic markers of fibrinolytic responses of older persons to exercise training

International Journal of Sports Medicine

Volumn 27, Issue 8, 2006, Pages 617-622

  Kulaputana, O ^a   Ghiu, I ^a   Phares, D A ^a   Ferrell, R E ^b   Macko, R F ^c   Goldberg, A P ^c   Hagberg, James M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

PAI 1 activity; PAI 1 genotype; t PA antigen; t PA genotype

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; EXERCISE; FEMALE; FIBRINOLYSIS; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSICAL STRESS; RISK FACTOR; THROMBOSIS;

AGED; ANTIGENS; EXERCISE; FEMALE; FIBRINOLYSIS; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33747095483     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865813     Document Type: Article

References (30)

1. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. Indianapolis, IN: American College of Sports Medicine, 1991: 35-45
2. Blair SN, Kohl III HW, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality: a prospective study of healthy men and women. J Am Med Assoc 1989; 262: 2395-2401
3. Chandler WL, Schwartz RS, Stratton JR, Vitiello MV. Effects of endurance training on the circadian rhythm of fibrinolysis in men and women. Med Sci Sports Exerc 1996; 28: 647-655
4. Cortellaro M, Cofrancesco E, Boschetti C, Mussoni L, Donati MB, Cardillo M, Catalano M, Gabrielli L, Lombardi B, Specchia G. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients A case-control study. The PLAT Group. Arterioscler Thromb 1993; 13: 1412-1417
5. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745
6. DeGeus E, Kluft C, DeBa VDL. Effects of exercise training on plasminogen activator inhibitor activity. Med Sci Sports Exerc 1992; 24: 1210-1219
7. Doggen C, Bertina R, Cats V, Reitsma P, Rosendaal F. The 4 G/5 G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thrombosis Haemost 1999; 82: 115-120
8. El-Sayed M, Lin X, Rattu A. Blood coagulation and fibrinolysis at rest and in response to maximal exercise before and after a physical conditioning programme. Blood Coagul Fibrinolysis 1995; 6: 747-752
9. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995; 92: 1851-1855
10. Eriksson P, Nilsson L, Karpe F, Hamsten A. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thrombrosis Vasc Biol 1998; 18: 20-26
11. Estelles A, Aznar J, Tormo G, Sapena P, Tormo V, Espana F. Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction. Thrombosis Research 1989; 55: 203-212
12. Hamsten A, DeFaire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9
13. Henry M, Chomiki N, Scarabin PY, Alessi MC, Peiretti F, Arveiler D, Ferrieres J, Evans A, Amouyel P, Poirier O, Cambien F, Juhan-Vague I. Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thrombrosis Vasc Biol 1997; 17: 851-858
14. Henry M, Tregouet DA, Alessi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan-Vague I. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Thrombrosis Vasc Biol 1998; 18: 84-91
15. Hooper WC, Lally C, Austin H, Renshaw M, Dilley A, Wenger N, Phillips D, Whitsett C, Rawlins P, Evatt B. The role of the t-PA I/D and PAI-1 4 G/5 G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 2000; 99: 223-230
16. Iacoviello L, Di Castelnuovo A, de Knijff P. Alu-repeat polymorphism in the t-PA gene, t-PA levels and the risk of familial AMI. Fibrinolysis 1996; 10: 13-18
17. Jern C, Ladenvall P, Wall U, Jern S. Gene polymorphism of t-PA is associated with forearm vascular t-PA release rate. Arterioscler Thrombrosis Vasc Biol 1999; 19: 454-459
18. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT study group. Circulation 1996; 94: 2057-2063
19. Krauss RM, Deckelbaum RJ, Ernst N. Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 1996; 94: 1795-1800
20. Margaglione M, Grandone E, Cappucci G, Colaizzo D, Giuliani N. Vecchione G, d'Addedda M, Di M. An alternative method for PAI-1 promoter polymorphism (4 G/5 G) typing. Thrombosis Haemost 1997; 77: 605-606
21. Rankinen T, Rauramaa R, Vaisanen S, Halonen P, Penttila I. Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise or fat modified diet. Fibrinolysis 1994; 8: 48-53
22. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-943
23. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168
24. Speiser W, Langer W, Pschaick A. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thrombosis Research 1988; 55: 203-212
25. Stratton JR, Chandler WL, Schwartz RS. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692-1697
26. Vaisanen SB, Humphries SE, Luong LA, Penttila I, Bouchard C, Rauramaa R. Regular exercise, plasminogen activator inhibitor-1 activity and the 4 G/5 G promoter polymorphism in the PAI-1 gene. Thrombosis Haemost 1999; 82: 1117-1120
27. van den Eijnden-Schrauwen Y, Lakenberg N, Emeis JJ, de Knijff P. Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene does not affect basal endothelial t-PA synthesis. Thrombosis Haemost 1995; 74: 1202-1208
28. van der Bom JG, de Knijff P, Haverkate F, Bots M, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE. Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 1997; 95: 2623-2627
29. Wilund KR, Colvin PL, Phares D, Goldberg AP, Hagberg JM. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults. Metabolism 2002; 51: 1053-1060
30. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ. Humphries SE, Evans A, Luc G, Cambou JP. The 4 G/5 G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thrombosis Haemost 1995; 74: 837-841